Finding Consensus miRNAs Silencing KLF1 Expression as A Promising Therapeutic Option of Sickle Cell Anemia
Abstract
1Sickle cell anemia (SCA) is the almost the severest hemoglobinopathy known with no cure till date. Patients with SCA has a shorter lifespan and suffer from painful crises and end-organ damages. The goal of this in silico work is to find the consensus miRNAs targeting KLF1 gene, responsible for HbF-to-HbA switching followed by generating the corresponding miRNA sponge for gene silencing purposes. 3 publicly available databases were searched, miRDB, miRWalk and TargetScan. Afterwards, the hybridization examination of the predicted miRNAs was evaluated. Finally, the design of miRNA sponge as a means to target miRNA was performed. In conclusion, hsa-miR-330-5p was the best miRNA targeting KLF1 gene in many aspects and its miRNA sponge sequence was provided.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.35
- Field percentile
- top 44%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
Mégane Brusson, Anne Chalumeau, … Annarita Miccio·bioRxiv·Dec 31, 2022
- miRNome profiling of clonal stem cells in Ph+ CML
M. S. Ruiz, M. B. Sanchez, … M. Bianchini·bioRxiv·Mar 16, 2020
- Identification and verification of the potential effect of therapeutic miRNA-mRNA pairs on ferroptosis in small cell lung cancer by bioinformatics analysis
Yuefeng Wu·bioRxiv·Jun 28, 2021
- A generative-AI framework for target-Specific MicroRNAs towards RNAi-based drug design
- Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease
Letizia Fontana, Pierre Martinucci, … Annarita Miccio·Cell Reports MedicinePeer-reviewed·Sep 27, 2025
- Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease
Jian-Ping Yang, Rachel Toughiri, … Shane R. Horman·PLoS ONEPeer-reviewed·Nov 6, 2024